Literature DB >> 13860492

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

N ALKJAERSIG, A P FLETCHER, S SHERRY.   

Abstract

Entities:  

Keywords:  FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HEMORRHAGIC DIATHESIS/etiology

Mesh：

Substances：

Year:  1962        PMID： 13860492      PMCID： PMC290992          DOI： 10.1172/JCI104547

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.

Authors:  N U BANG; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

2.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  Nature of the thrombin-inhibiting effect of incubated fibrinogen.

Authors:  D C TRIANTAPHYLLOPOULOS
Journal:  Am J Physiol       Date:  1959-09

4.  Effects of intravenous injections of the anticoagulant fraction of incubated fibrinogen on blood coagulation.

Authors:  D C TRIANTAPHYLLOPOULOS
Journal:  Can J Biochem Physiol       Date:  1960-08

5.  [The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties].

Authors:  V NUSSENZWEIG; M SELIGMANN; J PELMONT; P GRABAR
Journal:  Ann Inst Pasteur (Paris)       Date:  1961-03

6.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

7.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

8.  Studies on paracoagulation. Role of antithrombin VI.

Authors:  M KOPEC; E KOWALSKI; J STACHURSKA
Journal:  Thromb Diath Haemorrh       Date:  1960-12-15

9.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

10.  Anticoagulant effect of incubated fibrinogen.

Authors:  D C TRIANTAPHYLLOPOULOS
Journal:  Can J Biochem Physiol       Date:  1958-03
View more
  27 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.

Authors:  N ENDE; J V AUDITORE
Journal:  Ann Surg       Date:  1963-07       Impact factor: 12.969

3.  ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors:  A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

4.  ROLE OF PLATELET FIBRINOGEN IN THE REACTIONS OF PLATELETS TO THROMBIN.

Authors:  E E MORSE; D P JACKSON; C L CONLEY
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

5.  [Thromboelastographic studies on the blood clot structure in the Sanarelli-Shwartzman phenomenon].

Authors:  G MULLER-BERGHAUS; H J KRECKE; H G LASCH
Journal:  Klin Wochenschr       Date:  1963-03-01

6.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.

Authors:  N U BANG; A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

7.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

8.  Thrombolytic Therapy.

Authors: 
Journal:  Br Med J       Date:  1963-06-08

9.  Immune response in human subjects at high altitude.

Authors:  I S Chohan; I Singh; K Balakrishnan; G P Talwar
Journal:  Int J Biometeorol       Date:  1975-11       Impact factor: 3.787

10.  [The serum protein picture in obstetrical afibrinogenemia. Dysproteinemia as a consequence of uncoagulable fibrinogen derivatives].

Authors:  D F Steichele; H J Herschlein; I Woerner
Journal:  Klin Wochenschr       Date:  1966-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.